Search Results - "Chaganty, Bharat"
-
1
Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab
Published in Cancer letters (01-01-2017)“…Abstract Cetuximab inhibits HIF-1-regulated glycolysis in cancer cells, thereby reversing the Warburg effect and leading to inhibition of cancer cell…”
Get full text
Journal Article -
2
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion
Published in Cancer letters (28-08-2018)“…Here, we report that treatment of syngeneic mouse tumors transduced to overexpress human epidermal growth factor receptor-2 (HER2) with the anti-human HER2…”
Get full text
Journal Article -
3
Tumor Necrosis Factor Alpha Production from CD8⁺ T Cells Mediates Oviduct Pathological Sequelae following Primary Genital Chlamydia muridarum Infection
Published in Infection and Immunity (01-07-2011)“…The immunopathogenesis of Chlamydia trachomatis-induced oviduct pathological sequelae is not well understood. Mice genetically deficient in perforin…”
Get full text
Journal Article -
4
Redirecting host preexisting influenza A virus immunity for cancer immunotherapy
Published in Cancer Immunology, Immunotherapy (01-07-2022)“…We tested the concept that host preexisting influenza A virus immunity can be redirected to inhibit tumor growth and metastasis through systemic administration…”
Get full text
Journal Article -
5
Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation
Published in PloS one (09-02-2011)“…The role of antigen-specific secretory IgA (SIgA) has been studied extensively, whereas there is a limited body of evidence regarding the contribution of…”
Get full text
Journal Article -
6
Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
Published in Oncoimmunology (02-04-2016)“…It is increasingly recognized that trastuzumab, an antibody approved for treating human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer,…”
Get full text
Journal Article -
7
Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge
Published in Vaccine (08-03-2010)“…Abstract We have shown previously that vaccination with recombinant chlamydial protease-like activity factor (rCPAF) plus interleukin-12 as an adjuvant induces…”
Get full text
Journal Article -
8
Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice
Published in PloS one (31-05-2013)“…Chlamydia trachomatis is the most common bacterial sexually transmitted disease in the world and specifically in the United States, with the highest incidence…”
Get full text
Journal Article -
9
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo
Published in Blood cancer journal (New York) (02-11-2020)“…Therapeutically targeting CD138, a define multiple myeloma (MM) antigen, is not yet approved for patients. We here developed and determined the preclinical…”
Get full text
Journal Article -
10
Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life
Published in Laboratory investigation (01-10-2011)“…Respiratory dysfunction in adults has been correlated with neonatal Chlamydia trachomatis pneumonia in several studies, but a causal association has not been…”
Get full text
Journal Article -
11
Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α
Published in Frontiers in cellular and infection microbiology (2013)“…The role of TNF-α in chlamydial clearance is uncertain. Antibody-mediated depletion of TNF-α in mice and guinea pigs has been shown not to significantly affect…”
Get full text
Journal Article -
12
limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge
Published in FEMS immunology and medical microbiology (01-03-2009)“…Mice deficient in B cells (μmT mice) were used to evaluate the role of antibody in enhanced chlamydial clearance and reduction of pathology afforded by…”
Get full text
Journal Article -
13
A Novel CD138-Targeting Monoclonal Antibody Induces Potent Myeloma Killing and Further Synergizes with IMiDs or Bortezomib in in Vitro and In Vivo Preclinical Models of Human Multiple Myeloma
Published in Blood (05-11-2020)“…Immunotherapeutically targeting CD138 has not been successfully translated into substantial clinical benefit in multiple myeloma (MM) patients. We here…”
Get full text
Journal Article -
14
An Immune Based, Anti-CD138 Targeting Antibody for the Treatment of Multiple Myeloma
Published in Blood (29-11-2018)“…CD138 (Syndecan-1), a member of integral membrane family of heparan sulfate proteoglycans (HSPGS), is highly expressed on differentiated plasma cells (PC) and…”
Get full text
Journal Article -
15
Intranasal Vaccination with Chlamydia pneumoniae Induces Cross-Species Immunity against Genital Chlamydia muridarum Challenge in Mice. e64917
Published in PloS one (01-05-2013)“…Chlamydia trachomatis is the most common bacterial sexually transmitted disease in the world and specifically in the United States, with the highest incidence…”
Get full text
Journal Article -
16
Comparison of enzymatically active and denatured recombinant chlamydial protease like activity factor as protective immunogens against genital chlamydial challenge
Published 01-01-2009“…We have shown previously the efficacy of intranasal vaccination with recombinant chlamydial protease-like activity factor (rCPAF) plus interleukin-12 in the…”
Get full text
Dissertation -
17